Accumulating evidence demonstrates that IKKβ genetic KO and its chemical inhibition both block the NF-κB transduction to alleviate the tumor growth, such as pancreatic, colorectal, lung, and myeloma cancer cells 60-62. The gene discussed is NFKB1; the disease is neoplasm.